All peptides
Metabolic
Tirzepatide
Dual GIP/GLP-1 receptor agonist studied for weight management and glucose control.
Lyophilized vial
Tirzepatide is a dual GIP and GLP-1 receptor agonist that has become one of the most closely studied molecules in metabolic research. By engaging two incretin pathways at once, it is investigated for its effects on appetite signalling, insulin response, and body-weight regulation.
Research focus: Metabolic & Weight Management
Clinical research has explored its role in glucose control and substantial weight reduction, often comparing it against single-pathway GLP-1 agonists. Investigators are interested in how the combined mechanism influences satiety and energy balance.